 Vascular Biogenics Ltd went public after all The Israeli biotechnology companys bankers in a rare move had canceled its initial public offering in the US in August after several days of trading citing the failure of an investor to buy stock in the offering as expected But the deal was revived Tuesday night with Deutsche Bank AG leading a new smaller offering The
  